Sanaria Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Sanaria's estimated annual revenue is currently $11.2M per year.(i)
  • Sanaria's estimated revenue per employee is $155,000

Employee Data

  • Sanaria has 72 Employees.(i)
  • Sanaria grew their employee count by -1% last year.

Sanaria's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP International Projects and StrategyReveal Email/Phone
3
Associate Director, Manufacturing OperationsReveal Email/Phone
4
Chief Medical OfficerReveal Email/Phone
5
Senior DirectorReveal Email/Phone
6
Director, Mosquito ProductionReveal Email/Phone
7
Senior Director QualityReveal Email/Phone
8
Director Intellectual PropertyReveal Email/Phone
9
Chief Legal OfficerReveal Email/Phone
10
Managing Director, Vaccine extraction, Immunology and Model SystemsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M2-60%N/AN/A
#2
$2.9M38-31%$17.5MN/A
#3
$2.9M38-33%$10.5MN/A
#4
$19.8M1280%$69.4MN/A
#5
$9.6M62-15%N/AN/A
#6
$1.4M90%N/AN/A
#7
$2.5M160%N/AN/A
#8
$7.4M480%N/AN/A
#9
$0.2M1-83%N/AN/A
#10
$1.7M1122%N/AN/A
Add Company

What Is Sanaria?

Sanaria Inc. was founded in 2003. The company's mission is to develop and commercialize a malaria sporozoite vaccine against Plasmodium falciparum, the parasite responsible for more than 95 percent of malaria-associated severe illness and death world-wide, and the malaria parasite for which there is the most significant drug resistance. Sanaria plans to begin the first human trials of its Malaria Vaccine in 2009.

keywords:N/A

N/A

Total Funding

72

Number of Employees

$11.2M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Sanaria News

2022-04-17 - Several Memorial, PNG and Nederland track & field athletes ...

PNG's Sanaria Butler finished first in the long jump, triple jump and 400-meter dash. Nederland's Ke'Asia Hall finished second in the long...

2022-04-13 - Mexico Malaria Vaccines Market Size and Forecast (2022 ...

Sanaria Inc; Nobelpharma Co; Sumaya Biotech; GenVec. Mexico Malaria Vaccines Market Breakdown by Type: Pre-Erythrocytic Vaccine; Erythrocytic...

2022-04-13 - Malaria Vaccines Market Share And Size 2022 Analysis By ...

GlaxoSmithKline plc; Sanaria Inc; Nobelpharma Co; Sumaya Biotech; GenVec. Malaria Vaccines Market Breakdown by Type: Pre-Erythrocytic Vaccine...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.5M726%N/A
#2
$10.7M72-8%N/A
#3
$9.4M729%N/A
#4
$9.5M731%N/A
#5
$7.5M739%N/A